In a phase 1 double-blind randomized study, in which participants either received LY3298176 or a placebo, Coskun et al
As The New Yorker has observed, the rise of GLP-1s marks a shift not only in medicine but in cultureas appetite-modulating drugs move from treating diabetes toward shaping body ideals, identity, and social aspiration
Many people find that eating smaller meals more frequently works better than trying to eat three large meals
Is there a money-back guarantee
Possibly, but only if your disease is well-controlled, inflammatory markers are stable, and your gastroenterologist approves
Lancet (London, England) 403(10437):16351648